Talis Biomedical Corp

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2021-09-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notice of Effectiveness

Certification by an exchange approving securities for listing

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

GREENLIGHT CAPITAL INC: Major Shareholders

Lukowiak Andrew A: Initial statement of beneficial ownership of securities

Lukowiak Andrew A: Statement of changes in beneficial ownership of securities

Markovich Rebecca: Statement of changes in beneficial ownership of securities

BAKER JULIAN: Statement of changes in beneficial ownership of securities

Gilliam Melissa: Statement of changes in beneficial ownership of securities

Popovits Kimberly J: Statement of changes in beneficial ownership of securities

Ismagilov Rustem F.: Statement of changes in beneficial ownership of securities

Scott Randal W.: Statement of changes in beneficial ownership of securities

Posard Matthew L.: Statement of changes in beneficial ownership of securities

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(3)

Registration statement for specified transactions by certain issuers

Registration Withdrawal Request

Registration statement for specified transactions by certain issuers

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(4)

General form of registration statement for all companies including face-amount certificate companies

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.